ClinicalTrials.Veeva

Menu

Technological Based Rehabilitation on Individuals With Rheumatic Disease

A

Akdeniz University

Status

Enrolling

Conditions

Virtual Reality Therapy
Hand Rheumatism
Rheumatic Diseases

Treatments

Other: Virtual reality therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06385574
2023-088

Details and patient eligibility

About

Affects such as pain, swelling, tenderness, deformities, limitations, strength and function losses, skill and coordination deficiencies in the hand joints, which are frequently seen in rheumatism patients with hand involvement, are included in body structure and function disorders within the framework of International Classification of Function System. Leap Motion Controller is used in hand rehabilitation because it is small in size, low-cost, portable, non-contact, easy to use and provides visual and auditory feedback. The aim of our study is to examine the effect of technology-based rehabilitation on joint range of motion, grip strength, functionality and disease activity in adult individuals with rheumatic disease with hand involvement; and also to compare these effects with the effects of the hand rehabilitation program implemented under the guidance of a physiotherapist and the control group that continues its routine life.

Full description

In the study, 45 adult individuals diagnosed with rheumatic disease with hand involvement will be randomly divided into 3 groups. The first group will be given virtual reality exercises via Leap Motion Controller. Virtual reality exercises will be applied 30 minutes a day, 3 days a week for 8 weeks. To the second group, a conventional hand rehabilitation program will be applied under the supervision of a physiotherapist. The hand rehabilitation program will be applied 30 minutes a day, 3 days a week for 8 weeks. The third group will be the control group, which continues with its routine medications and is not included in any exercise program. After randomization, the individuals' joint range of motion, gross and fine grip strength, functionality, and disease activities will be evaluated. Evaluations will be made twice, at the beginning and at the end of the 8-week program. Disease Activity Score 28 (DAS 28), hand dynamometer, picnometer, Jebsen Hand Function Test, Nine Hole Peg Test, Duruoz Hand Index and Michigan Hand Outcome questionnairre will be used for evaluation.

Enrollment

45 estimated patients

Sex

All

Ages

18 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Having been diagnosed with a rheumatic disease that meets the latest criteria by a rheumatologist
  • Involvement in hand joints (pain, swelling, tenderness)
  • Being 18 years or older
  • Being on stable drug treatment for the last 6 months
  • Having sufficient cooperation to participate in the study
  • Volunteering to participate in the study

Exclusion criteria

  • Not volunteering to participate in the study
  • Having difficulty in cooperating at work
  • Having an additional orthopedic and/or neurological disease that will affect hand functions

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

45 participants in 3 patient groups

Virtual reality therapy group
Experimental group
Description:
Individuals in this group will be given hand exercises (wrist flexion, extension and deviations) for 45 minutes, 2 days a week for 8 weeks, using a leap motion control device and games selected in accordance with this device.
Treatment:
Other: Virtual reality therapy
Conventional exercise group
Experimental group
Description:
Hand exercises (wrist flexion, extension and deviations)) will be applied to individuals in this group under the supervision of a specialist physiotherapist for 45 minutes, 2 days a week for 8 weeks.
Treatment:
Other: Virtual reality therapy
Control group
No Intervention group
Description:
This group is waiting list. After the study, patients will do hand exercises with the leap motion controller device.

Trial contacts and locations

1

Loading...

Central trial contact

İshak Isik, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems